The multi-factorial nature of clinical multidrug resistance in cancer

多重耐药 流出 生物 抗药性 表观遗传学 肿瘤微环境 癌症 癌症研究 药品 药理学 生物信息学 遗传学 基因
作者
Yehuda G. Assaraf,Anamaria Brozović,Ana Cristina Gonçalves,Dana Jurkovičová,Aija Linē,Miguel Machuqueiro,Simona Saponara,Ana Bela Sarmento‐Ribeiro,Cristina P. R. Xavier,M. Helena Vasconcelos
出处
期刊:Drug Resistance Updates [Elsevier BV]
卷期号:46: 100645-100645 被引量:433
标识
DOI:10.1016/j.drup.2019.100645
摘要

Curative cancer therapy remains a major challenge particularly in cancers displaying multidrug resistance (MDR). The MDR phenotype is characterized by cross-resistance to a wide array of anticancer drugs harboring distinct structures and mechanisms of action. The multiple factors involved in mediating MDR may include host factors, tumor factors as well as tumor-host interactions. Among the host factors are genetic variants and drug-drug interactions. The plethora of tumor factors involves decreased drug uptake primarily via impaired influx transporters, increased drug efflux predominantly due to the overexpression of MDR efflux transporters of the ATP-binding cassette superfamily or due to drug efflux mediated by extracellular vesicles (EVs) or drug-loaded lysosomes undergoing exocytosis, deregulation of cell death mechanisms (i.e. anti-apoptotic modalities), enhanced DNA damage repair, epigenetic alterations and/or deregulation of microRNAs. The intratumor heterogeneity and dynamics, along with cancer stem cell plasticity, are important tumor factors. Among the tumor-host interactions are the role of the tumor microenvironment, selective pressure of various stressor conditions and agents, acidic pH and the intracellular transfer of traits mediated by EVs. The involvement of these diverse factors in MDR, highlights the need for precision medicine and real-time personalized treatments of individual cancer patients. In this review, written by a group of researchers from COST Action STRATAGEM “New diagnostic and therapeutic tools against multidrug resistant tumors”, we aim to bring together these multidisciplinary and interdisciplinary features of MDR cancers. Importantly, it is becoming increasingly clear that deciphering the molecular mechanisms underlying anticancer drug resistance, will pave the way towards the development of novel precision medicine treatment modalities that are able to surmount distinct and well-defined mechanisms of anticancer drug resistance.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
涛哥完成签到,获得积分10
1秒前
华仔应助无私的芹采纳,获得30
1秒前
SciGPT应助无私的芹采纳,获得30
1秒前
CodeCraft应助无私的芹采纳,获得30
1秒前
汉堡包应助无私的芹采纳,获得10
1秒前
852应助无私的芹采纳,获得10
1秒前
2秒前
英俊的铭应助无私的芹采纳,获得30
2秒前
bkagyin应助无私的芹采纳,获得10
2秒前
情怀应助无私的芹采纳,获得30
2秒前
完美世界应助无私的芹采纳,获得10
2秒前
HJJHJH发布了新的文献求助30
2秒前
矮小的采柳关注了科研通微信公众号
2秒前
不会学术的羊完成签到,获得积分10
4秒前
1111完成签到,获得积分10
4秒前
抹茶小豆完成签到,获得积分10
4秒前
SA发布了新的文献求助10
4秒前
我不是霍建华完成签到,获得积分10
5秒前
粱三问发布了新的文献求助10
5秒前
华仔应助Tony12采纳,获得10
6秒前
7秒前
木木完成签到 ,获得积分10
8秒前
9秒前
刘标发布了新的文献求助10
9秒前
充电宝应助玉洁采纳,获得10
10秒前
听风者完成签到,获得积分10
11秒前
聪慧小霜应助无私的芹采纳,获得10
12秒前
酷波er应助无私的芹采纳,获得10
12秒前
Lucas应助无私的芹采纳,获得30
12秒前
小二郎应助无私的芹采纳,获得30
12秒前
赘婿应助无私的芹采纳,获得30
12秒前
万能图书馆应助无私的芹采纳,获得10
12秒前
香蕉觅云应助无私的芹采纳,获得30
12秒前
12秒前
^_^发布了新的文献求助10
13秒前
111111发布了新的文献求助10
13秒前
Lucifer发布了新的文献求助10
13秒前
Zr完成签到,获得积分10
14秒前
DueDue0327发布了新的文献求助100
14秒前
15秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Cognitive Neuroscience: The Biology of the Mind 1000
Technical Brochure TB 814: LPIT applications in HV gas insulated switchgear 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Picture Books with Same-sex Parented Families: Unintentional Censorship 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3969628
求助须知:如何正确求助?哪些是违规求助? 3514448
关于积分的说明 11174217
捐赠科研通 3249822
什么是DOI,文献DOI怎么找? 1795000
邀请新用户注册赠送积分活动 875537
科研通“疑难数据库(出版商)”最低求助积分说明 804856